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Evaluation of hyperspectral technology for
assessing the presence and severity of peripheral
artery disease
Jason A. Chin, BSE,a,b Edward C. Wang, PhD,a and Melina R. Kibbe, MD,a,b Chicago, Ill
Background: Hyperspectral imaging is a novel technology that can noninvasively measure oxyhemoglobin and deoxyhe-
moglobin concentrations to create an anatomic oxygenation map. It has predicted healing of diabetic foot ulcers;
however, its ability to assess peripheral arterial disease (PAD) has not been studied. The aims of this study were to
determine if hyperspectral imaging could accurately assess the presence or absence of PAD and accurately predict PAD
severity.
Methods:This prospective study included consecutive consenting patients presenting to the vascular laboratory at the Jesse
Brown VA Medical Center during a 10-week period for a lower extremity arterial study, including ankle-brachial index
(ABI) and Doppler waveforms. Patients with lower extremity edema were excluded. Patients underwent hyperspectral
imaging at nine angiosomes on each extremity. Additional sites were imaged when tissue loss was present.Medical records
of enrolled patients were reviewed for demographic data, active medications, surgical history, and other information
pertinent to PAD. Patients were separated into no-PAD and PAD groups. Differences in hyperspectral values between the
groups were evaluated using the two-tailed t test. Analysis for differences in values over varying severities of PAD, as
defined by triphasic, biphasic, or monophasic Doppler waveforms, was conducted using one-way analysis of variance.
Hyperspectral values were correlated with the ABI using a Pearson bivariate linear correlation test.
Results: The study enrolled 126 patients (252 limbs). After exclusion of 15 patients, 111 patients were left for analysis,
including 46 (92 limbs) no-PAD patients and 65 (130 limbs) PAD patients. Groups differed in age, diabetes, coronary
artery disease, congestive heart failure, tobacco use, and insulin use. Deoxyhemoglobin values for the plantar metatarsal,
arch, and heel angiosomes were significantly different between patients with and without PAD (P < .005). Mean
deoxyhemoglobin values for the same three angiosomes showed significant differences between patients with monopha-
sic, biphasic, and triphasic waveforms (P < .05). In patients with PAD, there was also significant correlation between
deoxyhemoglobin values and ABI for the same three angiosomes (P  .001). Oxyhemoglobin values did not predict the
presence or absence of PAD, did not correlate with PAD severity, and did not correlate with the ABI.
Conclusions: These results suggest the ability of hyperspectral imaging to detect the presence of PAD. Hyperspectral
measurements can also evaluate different severities of PAD. (J Vasc Surg 2011;54:1679-88.)
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sPeripheral artery disease (PAD) is an increasingly prev-
alent disorder affecting millions of patients across the
world, including 8 million Americans. Among these pa-
tients, the prevalence of PAD among Americans aged 65
years is 12% to 20%.1 These patients are vulnerable to a
variety of sequela such as rest pain, lower extremity ulcer-
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doi:10.1016/j.jvs.2011.06.022tion, and even limb amputation. Critical limb ischemia
atients comprise 1% of all Americans with PAD, only 50%
f whom will remain amputation-free at 1 year.2
To combat this disease, effective diagnostic and prog-
ostic technologies are necessary for earlier detection and
reatment to avoid unnecessary complications and inter-
entions. Physicians currently use a combination of the
nkle-brachial Index (ABI), Doppler waveform analysis,
egmental limb pressures, and transcutaneous partial pres-
ure of oxygen for screening, diagnosis, and preprocedural
valuation. These methods have been well validated for
creening and diagnosis, but none have been shown to
redict with high specificity or sensitivity the healing of
issue loss in patients with PAD.3
The ABI and segmental pressures are limited by calci-
ed arteries where measurements are not accurate, as is
ommonly seen in patients with diabetes.2 The measure-
ent of transcutaneous partial pressure of oxygen can only
e performed on skin adjacent to tissue loss and is limited
y surrounding tissue edema and inflammation. Elevated
ranscutaneous oxygen levels have been associated with
uccessful healing; however, its usefulness has been con-
ested in active infection and swelling.4
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December 20111680 Chin et alHyperspectral imaging is a new technology that con-
structs spatial maps of tissue oxygenation through scanning
spectroscopy using wavelengths of visual light.5 It is non-
invasive, nonionizing, noncontact, and automated to re-
duce user-dependence. It has previously demonstrated an
ability to show changes in skin microcirculation in diabe-
tes.6 Further studies have shown a facility to predict healing
of diabetic foot ulcers with sensitivity, specificity, and pos-
itive predictive value of up to 86%, 88%, and 96%, respec-
tively.7 These studies included only small numbers of par-
ticipants or excluded patients with severe PAD.
Hyperspectral imaging may present a novel, fast, and
effective method to diagnose, monitor, and prognosticate
PAD and associated wound healing. The aims of the cur-
rent study were (1) to assess the ability of hyperspectral
imaging to evaluate the presence or absence of PAD, and
(2) to assess the ability of hyperspectral imaging to grade
the severity of PAD in lower extremities. We hypothesized
that oxygenation values returned by the imager would be
significantly different between patients with and without
PAD and that oxygenation values would also be signifi-
cantly different between patients with varying severities of
PAD as classified by standard methods.
METHODS
The protocol for this study was approved by the North-
western University Institutional Review Board and by the
Jesse Brown VA Research and Development Office. All
participating patients gave written informed consent before
undergoing hyperspectral imaging scans.
Patient cohort. Consecutive patients who presented
to the vascular laboratory of Jesse Brown VA Medical
Center in Chicago during a 10-week period from June
2009 to August 2009 for a lower extremity arterial flow
study were invited to participate in this study. The sole
exclusion criterion was lower extremity edema in the eval-
uated limb.
Each lower extremity of every patient was measured
and then analyzed separately in the study. Limbs were
initially divided into two groups: those with and without
PAD. The presence of PAD was established using the
criteria of an ABI 0.9 or a nontriphasic arterial Doppler
waveform in the evaluated limb.1,8,9 On further analysis for
severity of PAD, limbs were classified into three groups by
Doppler waveform analysis: (1) limbs with triphasic wave-
forms, (2) limbs with biphasic waveforms, and (3) limbs
with monophasic waveforms. These criteria and classifica-
tions are consistent with the Society of Vascular Surgery
and American College of Cardiology/American Heart As-
sociation guidelines and other published recommendations
for the diagnosis of PAD.10-12
Procedures. All patients were initially assessed for ba-
sic demographics, medical, and surgical history. Standard
noninvasive lower extremity arterial flow studies were con-
ducted, including measurement of the ABI; segmental
pressures for the upper thigh, lower thigh, calf, dorsalis
pedis, posterior tibial, metatarsal, first digit areas, and sec-
ond to fifth digits if first digit pressures were50 mm Hg; tnd arterial Doppler waveforms of the dorsalis pedis and
osterior tibial arteries.
Four registered vascular technicians performed the
ower extremity arterial flow studies per standard laboratory
rotocol. They were blinded to the hyperspectral imaging
esults because these scans were conducted after the com-
letion of the vascular laboratory studies. One of the au-
hors (J.C.) performed all of the hyperspectral imaging
tudies and data analysis subsequent to vascular laboratory
nterpretations and was not blinded to their results.
Hyperspectral imaging evaluation. Hyperspectral
maging data were collected using the OxyVu Hyperspec-
ral Tissue Oxygenation Mapping System (HyperMed,
altham, Mass). The technology has been previously de-
cribed with respect to physiologic imaging; but briefly,
yperspectral imaging works on the basis of scanning spec-
roscopy. Wavelengths of visual light between 500 and 660
m, which includes the absorption peaks for oxyhemoglo-
in and deoxyhemoglobin, are collected from each pixel in
n image and broken down by a spectral separator to
enerate a diffuse reflectance spectrum. These spectra from
ach pixel are compared against standard transmission so-
utions to determine the concentration of oxyhemoglobin
nd deoxyhemoglobin present in each visualized pixel.
These wavelengths of light penetrate to 1 to 2 mm
elow the skin and thus obtain information from the sub-
apillary plexus.7 The imager and hemoglobin calculation
lgorithm are calibrated for different skin pigmentations.
he OxyVu system used in this study had a 17-inch focal
istance and a resolution of 100 m. Cutaneous surface
emperature values in the imaged area were also obtained
nd documented by the OxyVu system using a remote
nfrared temperature sensor on the imaging unit. Scans of
pproximately 30 seconds were obtained from each imaged
rea after the imager was calibrated to anOxyVuCheck Pad
or each new patient.
All patients who received hyperspectral scans were im-
ged in a standard hospital bed with the head of the bed
levated to approximately 45°. Nine sites on each lower
xtremity were imaged for each patient and were deter-
ined from angiosomes, which are specific vascular beds
upplied by major named arteries. These sites were chosen
ith the idea that tissue oxygenation in watershed angio-
omes supplied by end arteries in the foot and ankle could
e preferentially affected by PAD.13 The nine sites chosen
n each limb were the anterior calf, lateral calf, posterome-
ial calf, lateral ankle, medial ankle, dorsal metatarsal, plan-
ar metatarsal, plantar arch, and plantar heel angiosomes
Fig 1).
OxyVu targets were placed in the center of each image.
xyhemoglobin and deoxyhemoglobin values were calcu-
ated automatically by the imaging system using a default
egion of interest consisting of a 1-cm donut around each
entral target with an area of 204 mm2 (Fig 2). Beyond the
ine sites imaged for each limb, any additional sites of tissue
oss were also imaged.
An OxyVu target was placed immediately adjacent to
he tissue loss area with oxyhemoglobin and deoxyhemo-
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Volume 54, Number 6 Chin et al 1681globin values calculated using a 1-cm-wide strip traced
directly around the area in the image. Oxyhemoglobin,
deoxyhemoglobin, and cutaneous surface temperature val-
ues were returned by the system for each image. Oxyhemo-
globin and deoxyhemoglobin values represent their quan-
tities in analyzed tissue and are influenced by microvascular
volume of capillary density and hemoglobin concentration.
These patients were contacted by standardized tele-
phone interview again at 6 and 12months after imaging for
follow-up evaluation of healing.
Statistical analysis. Data were entered into an Excel
file (Microsoft Corp, Redmond, Wash), and statistical anal-
ysis was performed using SPSS 19.0 software (SPSS Inc,
Chicago, Ill). Data were summarized using mean, median,
and standard deviation for continuous variables and count
and percentage for categoric variables. Differences between
the two primary analysis groups of PAD-positive and PAD-
negative limbs were calculated with a Pearson 2 or Fisher
exact test for dichotomous variables and the t test for
continuous variables. Further analysis for examining differ-
ences in oxyhemoglobin and deoxyhemoglobin with vary-
ing PAD severity subgroups, as determined by Doppler
waveform analysis, was performed using analysis of variance
(ANOVA). Hyperspectral parameters were correlated with
ABIs using a Pearson bivariate linear correlation analysis.
Statistical significance was established at a two-sided  
0.05.
RESULTS
Baseline characteristics. The study recruited 126 pa-
tients; however, 15 were excluded due to lower extremity
edema, which left 111 patients (222 limbs) for analysis.
This total included 65 patients (130 limbs) with PAD and
Fig 1. Locations are shown of the angiosomes that were imaged
for all patients. The black circles represent the approximate position
of the OxyVu targets.46 patients (92 limbs) without PAD. In the PAD group, 27 oatients (38 limbs) had an ABI 0.9 but abnormal Dopp-
er waveforms; and 4 patients (6 limbs) had an ABI 0.9
ut normal Doppler waveforms. The baseline demographic
nd comorbidity characteristics associated with all analyzed
imbs can be found in Table I.
Statistically significant differences were noted between
roups of limbs with and without PAD for age, presence of
iabetes, history of congestive heart failure (CHF), history
f coronary artery disease, use of tobacco8 weeks, use of
nsulin, and the ABI. The association of these factors was
onsistent with previously documented risk factors and
omorbidities of PAD.12 The groups were otherwise simi-
ar in factors, including body mass index (BMI); hyperten-
ion; use of cholesterol-lowering, antihypertensive, adren-
rgic medications, including inhaled bronchodilators; use
f steroids, including inhaled corticosteroids; use of supple-
ental oxygen; and prior lower extremity revascularization.
One limb in the PAD group and one limb in the
on-PAD group had ulcer sites with a history of infection.
lthough active infection and swelling may affect the reli-
bility of hyperspectral measurements, a review of images
rom these sites demonstrated no clinically apparent edema
ig 2. Visual, integrated oxyhemoglobin-deoxyhemoglobin, and
eoxyhemoglobin hyperspectral images are shown of the plantar
etatarsal angiosome for a (left) foot with no peripheral arterial
isease (PAD) and (right) a foot with PAD. The foot with PAD
as substantially decreased oxyhemoglobin and deoxyhemoglobin
alues throughout the angiosome.r erythema that would presumably compromise the reli-
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interest used to derive oxygenation values.
In addition to the standard nine sites for hyperspectral
imaging, 18 patients with 21 further sites of tissue loss were
recorded during the course of the study. Four of these
patients (four sites) were excluded because of unreliable
hyperspectral measurements caused by lower extremity
edema. An additional four patients (seven sites) could not
be found for follow-up at 6 and 12 months. Of the remain-
ing 10 patients (10 sites), 7 had undergone surgery that
would confound follow-up analysis, including amputation,
bypass grafting, and stenting.
Evaluation for the presence or absence of PAD.
The primary analysis comparing sites with and without
PAD showed no significant differences in hyperspectral
oxyhemoglobin values for the imaged angiosomes (Table
II). In contrast, mean deoxyhemoglobin values in the
plantar metatarsal (56.0 17.3 vs 49.7 12.9, P .004),
plantar arch (51.4  14.7 vs 45.1  12.6, P  .001),
and plantar heel (58.6  16.5 vs 50.8  14.6, P  .001)
angiosomes showed statistically significant differences for
non-PAD vs PAD limbs (Table II). In each case, deoxyhe-
moglobin values were elevated in the images of angiosomes
not affected by PAD. An example of OxyVu images ac-
Table I. Baseline demographic and clinical characteristics
for limbs with and without peripheral arterial disease
(PAD)
Variablesa
Without PAD With PAD
Pb(n  92) (n  130)
Age, years 64.4  10.9 67.4  9.4 .032
Body mass index, kg/m2 29.4  5.0 28.3  6.0 .123
Male 88 (95.7) 126 (96.9) .617
Diabetes 35 (38.0) 67 (51.5) .047
History of CHF 11 (12.0) 29 (22.3) .048
History of hypertension 75 (81.5) 113 (86.9) .271
History of CAD 15 (16.3) 43 (33.1) .005
Tobacco use 8 weeks 26 (28.3) 60 (46.2) .007
Caffeine use 12 hours 55 (59.8) 71 (54.6) .444
Medications
Statin 57 (62.0) 85 (65.4) .600
-blocker 44 (47.8) 68 (52.3) .511
ACE inhibitor 46 (50.0) 70 (53.8) .572
Insulin 15 (16.3) 37 (28.5) .035
Steroidc 20 (21.7) 16 (12.3) .060
Other adrenergic agentc 6 (6.5) 18 (13.8) .083
Other antihypertensive 58 (63.0) 76 (58.5) .492
Other diabetic agent 26 (28.3) 38 (29.2) .875
Supplemental oxygen use 1 (1.1) 1 (0.8) .805
Prior limb vascular surgery 8 (8.7) 20 (15.4) .139
SBP, mm Hg 134  19.6 136  21.4 .604
Ankle-brachial index 1.2  0.2 0.9  0.4 .001
ACE, Angiotensin-converting enzyme;CAD, coronary artery disease;CHF,
congestive heart failure; SBP, systolic blood pressure.
aContinuous data are shown as mean standard deviation; categoric data as
number (%).
bFisher exact test or 2 for categoric variables; t test for continuous variables.
P  .05 is significant.
cIncludes inhalers.quired at the plantar metatarsal angiosome in limbs with gnd without PAD can be seen in Fig 2. Although these
ngiosomes did show these statistically significant differ-
nces for deoxyhemoglobin, overlap existed in the ranges
f these values between PAD and non-PAD groups.
Mean cutaneous surface temperature measurements
Table II) were similar between groups at all imaged angio-
omes. This suggests that external temperature and patient
kin temperature played no significant role in regulating the
xygenation of imaged sites in this study.
Evaluation of the severity of PAD. Further investi-
ation comparing subgroups of limbs with varying PAD
everity as classified by dorsalis pedis Doppler waveform
nalysis demonstrated significant differences in the plantar
etatarsal (P .015), plantar arch (P .038), and plantar
eel (P  .006) angiosomes for mean deoxyhemoglobin
alues (Table III). Each of these sites showed downward
rends in deoxyhemoglobin content moving from triphasic
o biphasic to monophasic waveforms. This follows with
ecreasedmean deoxyhemoglobin in the initial PAD group
nd may indicate a restriction of deoxyhemoglobin flow in
ncreasingly severe PAD. Post hoc analysis illustrated that
he triphasic group had significantly higher deoxyhemoglo-
in content compared with monophasic and biphasic
roups (Fig 3). There was no difference in deoxyhemoglo-
in content between monophasic and biphasic groups for
ll of these angiosomes.
In further analysis to isolate maximally ischemic limbs,
e used three groups: (1) limbs with posterior tibial and
orsalis pedis monophasic waveforms, (2) all other limbs
ith PAD, and (3) limbs with no PAD. In contrast to the
bove results of decreased deoxyhemoglobin with more
evere waveforms, limbs with both monophasic waveforms
id not have significantly different hyperspectral-derived
xygenation values from other limbs with PAD, except at
he dorsal metatarsal angiosome, where limbs with both
onophasic waveforms actually had higher mean values of
eoxyhemoglobin (45.8 16.7 vs 38.2 11.6, P .011).
Differences in mean oxyhemoglobin values were de-
ected at the dorsal metatarsal (P  .041) and plantar
etatarsal (P  .031) angiosomes for severity classified by
orsalis pedis Doppler waveforms (Table III). Further dif-
erences were noted in mean deoxyhemoglobin values at
he dorsal metatarsal (P  .042) angiosome when severity
as classified by posterior tibial Doppler waveforms (Table
V). These comparisons of values across the varying sever-
ties of disease did not show any apparent trend.
A bivariate linear correlation analysis of limbs with PAD
howed statistically significant relationships between limb
BI and the hyperspectral-derived values for deoxyhemo-
lobin at the lateral ankle (R  –0.266, P  .005), dorsal
etatarsal (R  –0.257, 0.006), plantar metatarsal (R 
0.254, P  .004), plantar arch (R  –0.302, P  .001),
nd plantar heel (R  –0.192, P  .033). Although these
ivariate correlations are statistically significant, the clinical
ignificance is not affirmative given the very low correlation
oefficient value. Furthermore, this trend is different from
hat seen with the relationship between mean deoxyhemo-
lobin values and Doppler waveforms. Whereas Doppler
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monophasic waveforms (more severe disease), low ABIs
(more severe disease) showed increased deoxyhemoglobin
values. A scatter of the relationship between plantar arch
deoxyhemoglobin and ABI values is shown in Fig 4. ABI
was inversely predictive of plantar arch deoxyhemoglobin
(P  .001): for every 1-unit increase in ABI, there will be
approximately a 10-unit decrease in plantar arch deoxyhe-
moglobin. No sites showed any significant relationships
between oxyhemoglobin values and ABIs. Falsely elevated
ABIs were not excluded from this analysis; thus, hyperspec-
tral oxygenation values were also correlated with toe-
brachial index, posterior tibial ABI, and dorsalis pedis ABI,
which may adjust for these falsely elevated ABIs. These
results are tabulated in Table V and showed similarly low
correlation coefficients.
DISCUSSION
This prospective 10-week study of consecutive patients
from our vascular laboratory showed that hyperspectral
imaging might be useful in detecting differences in oxygen-
ation levels in the lower extremities of patients with and
Table II. Comparison of hyperspectral-derived mean varia
(PAD)
Variable
Sites without PAD
No. Mean  SD
Oxyhemoglobin
Anterior calf 91 29.0  14.
Lateral calf 90 30.5  15.
Lateral ankle 89 29.0  14.
Medial ankle 89 32.3  14.
Posteromedial calf 92 26.4  11.
Dorsal metatarsal 88 33.5  17.
Plantar metatarsal 92 73.3  21.
Plantar arch 90 52.0  22.
Plantar heel 90 71.5  20.
Deoxyhemoglobin
Anterior calf 91 35.2  9.6
Lateral calf 90 39.9  10.
Lateral ankle 89 43.5  12.
Medial ankle 89 42.8  11.
Posteromedial calf 92 37.2  10.
Dorsal metatarsal 88 41.4  12.
Plantar metatarsal 92 56.0  17.
Plantar arch 90 51.4  14.
Plantar heel 90 58.6  16.
Temperature
Anterior calf 91 31.4  1.3
Lateral calf 90 30.9  1.5
Lateral ankle 91 30.3  1.9
Medial ankle 90 30.7  1.9
Posteromedial calf 92 31.0  1.4
Dorsal metatarsal 89 29.4  3.1
Plantar metatarsal 92 29.2  3.4
Plantar arch 90 29.7  2.5
Plantar heel 91 27.7  3.1
SD, Standard deviation.
at test; values of P  .05 are significant.without PAD. Oxyhemoglobin content in the skin of PAD nnd non-PAD limbs did not show any differences; however,
eoxyhemoglobin content was reduced in the plantar an-
iosomes of patients with PAD. Furthermore, these same
ngiosomes also showed decreasing deoxyhemoglobin
ontent with increasing severity of disease. In contrast to
revious studies of hyperspectral imaging technology,
hich predominately studied patients with diabetes and
xcluded patients with PAD, our study included patients
ith a spectrum of PAD, including critical limb ischemia.
hus, our data suggest that hyperspectral imaging may be a
seful tool for the diagnosis and evaluation of patients with
AD.
Our results are seemingly in contrast to a recent study
y Jafari-Saraf and Gordon,14 which demonstrated no cor-
elation between the ABI and hyperspectral oxygenation
arameters in patients being evaluated for PAD, excluding
hose patients with calcified tibial vessels. They showed that
xyhemoglobin values and hemoglobin oxygen saturation
alues did not exhibit significant differences across ABI
roups of 0.45, 0.45 to 0.9, and 0.9. However, these
uthors only studied values at the dorsum of the foot and
nkle, in contrast to our study, which included values at
among sites with and without peripheral arterial disease
Sites with PAD
PaNo. Mean  SD
126 27.8  13.9 .537
121 27.7  11.2 .128
109 27.8  11.7 .524
115 32.3  13.3 .986
120 25.9  11.9 .754
113 34.8  14.9 .561
126 71.5  21.4 .518
126 50.6  18.9 .632
127 72.7  24.5 .704
126 34.9  10.0 .809
121 38.9  11.3 .525
109 41.0  12.1 .155
115 41.3  12.2 .374
120 36.8  10.1 .815
113 39.9  13.2 .398
126 49.7  12.9 .004
126 45.1  12.6 .001
127 50.8  14.6 .001
126 31.1  1.2 .072
121 30.7  1.8 .469
120 30.1  2.1 .473
121 30.4  1.9 .230
123 30.7  1.4 .296
124 29.2  2.9 .678
127 29.5  3.0 .542
128 29.7  2.4 .956
129 28.2  3.0 .289bles
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December 20111684 Chin et altudy of Jafari-Saraf and Gordon. One explanation for why
e found a difference in the values for the plantar angio-
omes is that they are covered by glabrous skin, which is
ich in arteriovenous anastomoses, have generally higher
xygenation levels, and are generally more reactive com-
ared with skin over other body parts.5
That we found significant results in these plantar sites as
pposed to areas more proximal in the leg is also consistent
ith the concept of angiosomes described by Galiano13
xplaining that lower extremity angiosomes reach a water-
hed status in the foot. Also of note, the Jafari-Saraf and
ordon study excluded limbs with noncompressible tibial
essels. Our study did not use this exclusion criteria because
ur definition of PAD included limbs with an unreliable
BI by taking into account nontriphasic Doppler wave-
orms, as is currently recommended.10,11 Despite the de-
reasedmean value of deoxyhemoglobin we found in PAD-
ffected angiosomes, the distribution of values in these
roups does show substantial spread and overlap (Fig 3). A
g sites of varying peripheral arterial disease severity by
Biphasic Triphasic
PaMean  SD No. Mean  SD
28.0  14.1 108 28.8  13.7 .825
27.7  11.6 106 29.9  14.1 .494
27.5  10.5 104 28.8  14.3 .793
31.6  12.4 105 32.4  13.7 .636
26.6  13.1 108 26.1  10.7 .630
31.9  12.1 100 33.9  17.1 .041
74.8  19.3 109 73.3  21.2 .031
51.4  16.4 107 52.0  21.4 .722
74.0  23.6 107 73.1  21.6 .218
35.2  10.9 108 35.0  9.2 .985
38.9  11.0 106 39.6  9.8 .801
41.3  12.2 104 42.9  11.8 .613
40.9  13.1 105 43.0  10.8 .498
36.9  11.2 108 37.1  9.7 .983
38.2  11.3 100 41.3  12.0 .084
49.5  11.9 109 55.3  16.4 .015
45.8  10.9 107 50.2  14.6 .038
50.7  12.7 107 57.6  15.9 .006
31.2  1.2 108 31.4  1.3 .051
30.6  1.9 106 30.9  1.5 .338
30.3  2.0 106 30.4  1.9 .168
30.5  1.9 107 30.7  1.8 .191
30.8  1.4 109 30.9  1.4 .602
29.3  3.0 105 29.4  3.1 .510
29.7  3.1 109 29.3  3.3 .460
29.9  2.4 107 29.7  2.4 .592
27.9  3.1 108 27.9  3.0 .428Fig 3. Mean hyperspectral technology (HT) deoxyhemoglobin
(Deoxy) values are shown with the standard deviation (error bars)
for the plantar metatarsal, plantar arch, and plantar heel angio-
somes in individuals with monophasic, biphasic, and triphasic
dorsalis pedis waveforms. Individuals with monophasic and bipha-
sic waveforms have lower mean deoxyhemoglobin values thanTable III. Comparison of hyperspectral-derived variables amon
dorsalis pedis artery Doppler waveform analysis
Variable
Monophasic
No. Mean  SD No.
Oxyhemoglobin
Anterior calf 34 27.2  16.3 73
Lateral calf 32 27.9  12.2 71
Lateral ankle 29 29.0  14.9 65
Medial ankle 29 34.4  15.8 69
Posteromedial calf 31 24.2  10.9 72
Dorsal metatarsal 32 40.5  19.0 68
Plantar metatarsal 34 63.6  24.0 74
Plantar arch 35 48.8  24.9 73
Plantar heel 35 66.1  26.1 73
Deoxyhemoglobin
Anterior calf 34 35.2  9.2 73
Lateral calf 32 40.4  13.6 71
Lateral ankle 29 41.0  12.9 65
Medial ankle 29 41.7  10.7 69
Posteromedial calf 31 37.1  9.2 72
Dorsal metatarsal 32 43.8  16.4 68
Plantar metatarsal 34 49.0  16.4 74
Plantar arch 35 44.5  16.1 73
Plantar heel 35 50.7  19.9 73
Temperature
Anterior calf 34 30.8  1.4 73
Lateral calf 32 30.6  1.7 71
Lateral ankle 33 29.6  2.3 72
Medial ankle 33 30.0  2.0 70
Posteromedial calf 33 30.7  1.5 72
Dorsal metatarsal 34 28.7  2.9 72
Plantar metatarsal 34 28.9  3.1 75
Plantar arch 35 29.4  2.6 75
Plantar heel 35 28.6  2.9 75
SD, Standard deviation.
aAnalysis of variance test; P  .05 is significant.actor contributing to the statistical significance of our
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cruited in our study compared with previous trials.5,7,14
If hyperspectral imaging is to be clinically useful in the
future, a much more thorough evaluation will need to be
undertaken to determine the valid ranges and benchmarks
for determining diseased vs nondiseased limbs. Once these
benchmarks are determined and a model for predicting
wound healing in PAD is created, a prospective study can
be conducted to determine the sensitivity and specificity of
this technology.5,7
The differences we found in deoxyhemoglobin and not
in oxyhemoglobin—except for oxyhemoglobin in two an-
giosomes compared for severity by dorsalis pedis Doppler
waveforms—are further notable because no previous study,
to our knowledge, has documented differences in deoxy-
hemoglobin without changes in oxyhemoglobin as well.
Indeed, previous studies of diabetes and ischemic models
have all shown oxyhemoglobin to decrease in diseased and
ischemic states.5,6,15,16 A study of hyperspectral technol-
ogy by Nagaoka et al16 actually shows oxyhemoglobin
decreasing and deoxyhemoglobin increasing in the middle
finger of an individual whose brachial artery was com-
Table IV. Comparison of hyperspectral-derived variables a
severity by posterior tibial artery Doppler waveform analysi
Variable
Monophasic
No. Mean  SD N
Oxyhemoglobin
Anterior calf 31 26.6  16.4 79
Lateral calf 29 27.9  11.9 77
Lateral ankle 24 28.5  15.5 73
Medial ankle 25 32.7  16.5 77
Posteromedial calf 28 24.3  13.3 78
Dorsal metatarsal 29 38.9  20.6 73
Plantar metatarsal 31 64.2  24.1 80
Plantar arch 31 49  25.6 80
Plantar heel 32 67.5  23.6 79
Deoxyhemoglobin
Anterior calf 31 36.0  10.8 79
Lateral calf 29 39.2  13.8 77
Lateral ankle 24 44.1  14.0 73
Medial ankle 25 43.5  13.6 77
Posteromedial calf 28 37.9  9.5 78
Dorsal metatarsal 29 44.7  16.5 73
Plantar metatarsal 31 50.3  16.0 80
Plantar arch 31 47.3  16.5 80
Plantar heel 32 53.3  18.5 79
Temperature
Anterior calf 31 31.0  1.3 79
Lateral calf 29 30.8  1.8 77
Lateral ankle 30 29.8  2.4 77
Medial ankle 30 30.0  2.1 77
Posteromedial calf 30 30.8  1.5 78
Dorsal metatarsal 32 28.7  3.0 76
Plantar metatarsal 31 28.8  3.2 81
Plantar arch 32 29.3  2.7 81
Plantar heel 32 28.4  3.0 81
SD, Standard deviation.
aAnalysis of variance test. P  .05 is significant.pressed for 1 minute. This is thought to indicate increased aissue consumption of oxygenated hemoglobin with an
ncrease in deoxygenated hemoglobin secondary to block-
ge in blood flow.
A possible reason for the difference found in our data is
he physiology of PAD, which is a chronic process affecting
lood flow in both macroperipheral and microperipheral
rteries. The peripheral sympathetic postural autonomic
asoregulation mechanism, the venoarteriolar response, is
mpaired in PAD. This has been demonstrated by increased
kin blood flow in PAD limbs in the dependent position
which was the case in our study) due to decreased precap-
llary resistance.17 As the hyperspectral imager gathers data
rom the subpapillary plexus, it can be thought to examine
his increased dependent skin blood flow, which could
anifest as unaffected oxyhemoglobin levels with de-
reased deoxyhemoglobin levels due to less than maximal
xygen extraction in more perfused skin.
In addition to all the changes noted between purely
AD and non-PAD groups, the trend of decreasing hyper-
pectral deoxyhemoglobin when evaluating severity of
AD by Doppler waveform should not be understated.
his would support the idea that decreased flow of blood
g sites of varying peripheral arterial disease (PAD)
Biphasic Triphasic
PaMean  SD No. Mean  SD
28.2  13.6 104 28.8  14.1 .893
27.7  11.3 103 30  14.4 .473
28.4  10.6 101 28.3  14.4 .990
32.6  12.6 101 32.1  13.6 .967
26.3  11.4 105 26.3  11.3 .713
33.8  12.4 98 33.2  16.9 .238
75.1  20.2 105 72.3  20.8 .078
51.2  15.7 103 51.9  22.1 .888
76.2  25.4 103 70.6  20.8 .218
34.7  9.4 104 35.2  9.8 .900
39.2  10.9 103 39.8  9.9 .900
40.1  11.5 101 43.1  11.9 .185
40.7  12.0 101 42.9  10.7 .375
36.9  10.4 105 36.9  10.2 .900
38.1  11.7 98 41.3  11.8 .042
50.1  11.7 105 54.6  17.1 .164
44.8  11.2 103 50.3  14.5 .051
50.7  13.5 103 56.9  16.6 .069
31.2  1.3 104 31.4  1.2 .389
30.6  1.9 103 30.9  1.4 .548
30.2  2.0 104 30.3  1.9 .437
30.5  1.9 102 30.7  1.8 .374
30.8  1.5 105 30.9  1.4 .898
29.3  3.0 102 29.4  3.1 .669
29.7  3.0 105 29.2  3.3 .426
29.9  2.4 103 29.7  2.4 .669
28.1  3.0 104 27.8  3.1 .640mon
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trend in deoxyhemoglobin with increasing severity of PAD
can be clearly seen in Fig 3. Although we did note insignif-
icant changes in hyperspectral values between limbs with
monophasic and biphasic Doppler waveforms, this may be
due to the smaller number of limbs for analysis in both of
these groups compared with the triphasic group. A greater
number of more severely diseased limbs may have shown a
stronger relationship at this level of PAD. Future investiga-
tions of this subject will need to address adequate recruit-
ment of all severities of PAD.
Our study is not without limitations. One potential
limitation is the baseline disparities between the PAD and
non-PAD cohorts. Significantly more limbs in the PAD
group were associated with diabetes, congestive heart fail-
ure, coronary artery disease, and recent tobacco use. Al-
though this is not completely unexpected, given that these
are well-known risk factors and comorbidities for PAD,
they may have adversely affected the results of the analysis.
This is most suspect for diabetes, given the previous studies
of hyperspectral technology examining diabetic microcir-
culation and foot ulcer healing. However, the results of our
study do not mirror the oxygenation patterns found in the
previous diabetic studies that excluded patients with
Fig 4. Linear regression of plantar arch deoxyhemoglob
with peripheral arterial disease. The data show a statistica
and ABI for this angiosome (P  .001).PAD.5-7 Use of other vasoactive substances, such as caf- teine, adrenergic agents, and antihypertensive agents,
hich may have had a more direct effect on the circulatory
ystem and tissue perfusion, was well-matched between
roups.
Respiratory diseases, such as chronic obstructive pul-
onary disease (COPD), could also play a direct role in
he detected hyperspectral oxygenation values that may
ot be in proportion to mechanical indices like ABI and
oppler waveforms. The technical outline for the imag-
ng system specifies that no oxygen measurement ranges
ave been established for patients on oxygen assistance.
lthough we did not exclude COPD patients from the
tudy or interview participants about its presence, we did
ecord several markers, including use of adrenergic agents,
ncluding inhaled bronchodilators; steroids, including in-
aled corticosteroids; and supplemental oxygen that make
s confident it did not significantly confound results. Fur-
her trials will need control for these factors.
Another notable consideration for the data analysis is
he possibility of type 1 error. The multiple comparisons
hat were made increased the probability of returning a
alse-positive difference. In the primary analysis, 18 values
ere compared for oxygenation (9 angiosomes each for
xyhemoglobin and deoxyhemoglobin), determined by
lues is shown for the ankle-brachial index (ABI) in limbs
nificant inverse relationship between deoxyhemoglobinin va
lly sighe presence or absence of PAD, and in the subgroup
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waveforms. However, high levels of significance were
achieved in the primary analysis, with P  .004 for the
plantar metatarsal, P  .001 for the plantar arch, and P 
.001 for the plantar heel. Furthermore, oxygenation values
in adjacent angisomes tend to correlate with one another;
for example, calf angiosome mean values were all lower
than plantar angiosome mean values. The test results in
these regions of adjacent angiosomes are likely to be at least
partially dependent on one another. Thus, we are confident
the differences detected in these results are significant.
One aspect of the hyperspectral images that this study
did not directly address is its anatomic mapping of oxygen-
ation throughout the scanned area. The data presented in
this study were limited to the relatively small regions of
interest around the OxyVu targets in each image. One of
the possibly powerful capabilities of hyperspectral imaging
is to supply oxygenation information beyond these point
measurements in an anatomic view that could be amenable
to simple color and pattern recognition by technicians after
further study and development. For instances where the
automatically sampled region of interest may coincidentally
Table V. Pearson correlation coefficient for linear relation
for limbs with peripheral arterial disease (PAD)
Variable
ABI TB
No. R P No. R
Oxyhemoglobin
Anterior calf 123 	0.016 .863 126 0.05
Lateral calf 118 0.009 .919 121 0.01
Lateral ankle 108 	0.029 .767 109 0.00
Medial ankle 113 0.044 .646 115 0.02
Posteromedial calf 118 0.026 .777 120 0.05
Dorsal metatarsal 111 0.044 .647 113 	0.04
Plantar metatarsal 124 	0.049 .588 126 0.30
Plantar arch 124 	0.104 .252 126 0.13
Plantar heal 124 0.049 .589 127 0.17
Deoxyhemoglobin
Anterior calf 123 	0.101 .267 126 0.00
Lateral calf 118 	0.133 .152 121 	0.02
Lateral ankle 108 	0.266 .005 109 	0.16
Medial ankle 113 	0.136 .151 115 	0.12
Posteromedial calf 118 0.018 .848 120 0.04
Dorsal metatarsal 111 	0.257 .006 113 	0.12
Plantar metatarsal 124 	0.254 .004 126 	0.02
Plantar arch 124 	0.302 .001 126 	0.00
Plantar heel 124 	0.192 .033 130 	0.08
Temperature
Anterior calf 123 0.248 .006 126 0.16
Lateral calf 118 0.239 .009 121 0.05
Lateral ankle 119 0.298 .001 120 0.17
Medial ankle 119 0.327 .000 121 0.21
Posteromedial calf 121 0.218 .016 123 0.09
Dorsal metatarsal 121 0.267 .003 124 0.13
Plantar metatarsal 125 0.270 .002 127 0.17
Plantar arch 126 0.271 .002 128 0.15
Plantar heel 126 0.287 .001 129 0.02
ABI, Ankle-brachial index; TBI, toe-brachial index.fall in an oxygenation area not representative of the rest of Phe body part, the rapidly interpretable color mapping in
eturned images could be invaluable.
Another facet of hyperspectral imaging that our data
ould not address is the reproducibility of hyperspectral-
erived oxygenation values in our participants over time.
lthough one individual that was initially recruited had
epeat studies, this person had to be excluded from the
nalysis due to lower extremity edema.
Although no large-scale studies have been undertaken
or the reliability of measurements in subjects with PAD,
yperspectral imaging has been tested for reliability and
stablishment of normative oxygenation values in asymp-
omatic patients with subgroups undergoing repeat same-
ite, same-subject testing after 8 hours and after transient
uff-induced ischemia with reproducible hyperspectral-
erived results.18 On the basis of these past results, it is
easonable to believe the same technology would perform
imilarly in our study.
ONCLUSIONS
Hyperspectral imaging presents an interesting new de-
elopment for the diagnostic imaging and evaluation of
of hyperspectral-derived variables with pressure indexes
ABI
Posterior tibial Dorsalis pedis
P No. R P No. R P
.525 121 0.041 .654 123 	0.03 .744
.867 117 0.019 .843 118 	0.029 .752
.940 107 0.016 .866 108 0.027 .783
.812 112 0.046 .634 113 0.123 .194
.526 117 0.012 .900 118 0.052 .576
.656 110 0.031 .751 111 0.060 .532
.001 122 0.013 .886 124 	0.059 .515
.134 122 	0.071 .437 124 	0.073 .420
.048 122 0.104 .257 124 0.027 .767
.990 121 	0.031 .74 123 	0.109 .232
.821 117 	0.085 .362 118 	0.073 .433
.097 107 	0.315 .001 108 	0.180 .062
.184 112 	0.168 .077 113 	0.046 .627
.612 117 	0.001 .994 118 0.088 .343
.176 110 	0.298 .002 111 	0.202 .033
.783 122 	0.213 .018 124 	0.201 .025
.928 122 	0.329 .001 124 	0.212 .018
.359 122 	0.165 .069 124 	0.123 .175
.067 121 0.244 .007 123 0.275 .002
.552 117 0.263 .004 118 0.184 .046
.050 118 0.298 .001 119 0.284 .002
.016 117 0.392 .001 119 0.291 .001
.324 119 0.265 .004 121 0.211 .020
.148 119 0.297 .001 121 0.255 .005
.052 123 0.301 .001 125 0.260 .003
.086 124 0.305 .001 126 0.235 .008
.822 124 0.323 .001 126 0.194 .029ships
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replace existing technologies, our analysis has demon-
strated its utility in distinguishing ischemia from normal
flow states. With further study and understanding of how
this technology works, it may be a valuable tool for the
prediction of wound healing in severely ischemic patients.
Other possible uses for hyperspectral imaging includemon-
itoring and follow-up of revascularization interventions.
Future work concentrating on the recruitment of severe
PAD and critical limb ischemia patients should yield more
immediately applicable results to the surgical management
of tissue loss in those patients. A robust study concentrating
on the recruitment of severe PAD and critical limb ischemia
patients and analyzing its use in predicting the healing of
PAD-associated tissue loss and need for revascularization or
amputation should yield more immediately applicable re-
sults in the surgical management of tissue loss. The clinical
applicability of hyperspectral imaging with regards to PAD
is clearly still in its adolescence and requires much more
validation before it can be used safely and effectively. How-
ever, this and other studies suggest an intriguing new
opportunity for the physician and vascular laboratory.
We thank the technologists and clerks at the Jesse
Brown VA Vascular Laboratory for their help in collecting
arterial flow data for this study.
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